Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Open-label, Long-term, Multi-center, Registry to Assess the Safety and Efficacy of the Bioness StimRouter Neuromodulation System in Subjects With Chronic Pain of Peripheral Nerve Origin

NCT03913689 is registered in ClinicalTrials.gov with Bioness Inc as lead sponsor.

NCT NCT03913689
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03913689 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Open-label, Long-term, Multi-center, Registry to Assess the Safety and Efficacy of the Bioness StimRouter Neuromodulation System in Subjects With Chronic Pain of Peripheral Nerve Origin
Lead sponsor
Bioness Inc
Phase
Observational
Overall status
Completed
Start date
June 26, 2019
Completion date
June 30, 2024
Enrollment
62 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

chronic pain, nervous system diseases, peripheral nerve injuries, peripheral nervous, peripheral nervous system diseases, peripheral nervous system problem, peripheral neuropathy